Product Detail
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone
Nicotine Nitrosamine
Stock Status: In Stock
Login to view price
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Nitrosamine
API Family
Nicotine
Storage
Store at refrigerator (2-8°C) for long term storage
Hazard Information
Refer MSDS for complete information.
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Product Information
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone is listed under Nitrosamine. It is associated with Nicotine and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-30578.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone
CAS No.
64091-91-4
CAT No.
CS-T-30578
Molecular Formula
C10H13N3O2
Molecular Weight
207.23
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
SMILES
O=C(CCCN(N=O)C)C1=CC=CN=C1
IUPAC Name
N-methyl-N-(4-oxo-4-(pyridin-3-yl)butyl)nitrous amide
Purity by HPLC
100.00% (Mixture of isomers)
Hazard Compound
Refer MSDS for complete information.
Description
Overview
This compound was present in the highest concentrations in smokeless tobacco out of the nitrosamines identified. It is likely to be important in the etiology of cancers of the lung, oral cavity, and pancreas in people who use tabacco products. Readily produces cancer in rats and hamsters. Carcinogen.
Synonyms
4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; NNK;
Application Notes
This compound was present in the highest concentrations in smokeless tobacco out of the nitrosamines identified. It is likely to be important in the etiology of cancers of the lung, oral cavity, and pancreas in people who use tabacco products. Readily produces cancer in rats and hamsters. Carcinogen.
References
Koenigs, L., et al.: Drug Metab. Dispos., 25, 1407 (1997), Gu, J., et al.: Toxicol. Appl. Pharmacol., 165, 158 (2000), Jalas, J., et al.: Chem. Res. Toxicol., 18, 95(2005), Zhu, L., et al.: Drug Metab. Dispos., 34, 1672(2006),
